Official Guidance (FQ4 FY26 & Full-Year FY26):
Mgmt Quotes:
| Metric | Value | Speaker/Context |
|---|---|---|
| Q3 Enterprise Revenue | $9.7B | CFO |
| Q3 Comparable Sales Growth | +2.7% | CEO, CFO |
| Q3 Adjusted Operating Income Rate | 4.0% | CEO, CFO |
| Q3 Adjusted Diluted EPS | $1.40 | CEO, CFO |
| Q3 Domestic Gross Profit Rate | 23.3% | CFO |
| Q3 International Gross Profit Rate | 22.8% | CFO |
| Q3 Best Buy Health Impairment | $192M (pretax noncash) | CFO |
| FY26 Full-Year Revenue Guidance | $41.65B–$41.95B | CFO |
| FY26 Full-Year Comparable Sales Guidance | +0.5% to +1.2% | CFO |
| FY26 Full-Year Adjusted Diluted EPS Guidance | $6.25–$6.35 | CFO |
| FY26 Full-Year CapEx Guidance | ~$700M | CFO |
| FQ4 Comparable Sales Guidance | (‑1%) to (+1%) | CFO |
| FQ4 Adjusted Operating Income Rate Guidance | 4.8%–4.9% | CFO |